ITW
39
2
MCHP
47
2
HSIC
64
-3
RSG
48
-23
LEN
36
-5
LH
43
-5
FTI
63
3
GIS
64
3
MET
66
2
KMX
40
-7
EQIX
59
6
DUK
55
3
GME
75
4
UAL
72
-13
EBAY
52
4
AMG
71
-3
PPL
54
-26
COP
44
4
MOS
29
3
BMY
74
-2
ITW
39
2
MCHP
47
2
HSIC
64
-3
RSG
48
-23
LEN
36
-5
LH
43
-5
FTI
63
3
GIS
64
3
MET
66
2
KMX
40
-7
EQIX
59
6
DUK
55
3
GME
75
4
UAL
72
-13
EBAY
52
4
AMG
71
-3
PPL
54
-26
COP
44
4
MOS
29
3
BMY
74
-2
Financhill
Back

PGIM Total Return Bond ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
39

PTRB
PGIM Total Return Bond ETF

Last Price:
$42.20
Seasonality Move:
0.95%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.51
Seasonality Move:
-18.07%
Sell
39
PGIM Total Return Bond ETF (PTRB) is a Sell

Is PGIM Total Return Bond ETF a Buy, Sell or Hold?

  • The current PGIM Total Return Bond ETF [PTRB] share price is $42.12. The Score for PTRB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • PTRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTRB Stock Price Chart

What is PGIM Total Return Bond ETF's stock price today?

  • The PGIM Total Return Bond ETF share price today is $42.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTRB is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

PTRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.36 Buy
Relative Strength Index (14 RSI): 45.47 Sell
Chaikin Money Flow: 6892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.07 - 42.37) Sell
Bollinger Bands (100): (41.86 - 42.44) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: -20975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.65) Sell
Bollinger Bands (100): (12.3 - 15.28) Sell

PTRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.08 Buy
20-day SMA: 42.22 Sell
50-day SMA: 42.31 Sell
200-day SMA: 41.74 Buy
8-day EMA: 9.36 Buy
20-day EMA: 4.01 Buy
50-day EMA: 1.65 Buy
200-day EMA: 0.42 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.32 Sell
20-day SMA: 11.56 Buy
50-day SMA: 12.92 Sell
200-day SMA: 11.86 Sell
8-day EMA: 12.05 Sell
20-day EMA: 12.05 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.23 Sell

PGIM Total Return Bond ETF Earnings Growth & PTRB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

PGIM Total Return Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):